Francisco González

Jul 24, 2024 | bioprocessonline.com | Enrico Zanetti |Francisco Gonzalez |Francisco González |Cristina Brinkmann

mRNA Vaccine and Therapeutics ManufacturingDiscover our solutions on how to optimize production of plasmid DNA, maximize the recovery and ensure efficient purity of the mRNA, as well as develop an efficient mRNA formulation. Discover how!FOCUS ON DOWNSTREAM MANUFACTURINGThis article demystifies the manufacture of mRNA encapsulated in lipid nanoparticles across unit operations for plasmid linearization, drug substance (DS) manufacture, and drug product (DP) manufacture.

Feb 3, 2024 | drugdeliveryleader.com | Katherine Bowers |Francisco Gonzalez |Francisco González

By Katherine Bowers and Francisco Gonzalez One of the most critical, yet often overlooked, aspects of a successful biological pharmaceutical is the formulation used to create a stable drug product for pre-clinical, clinical, and commercial applications. A molecule with great therapeutic potential is only as good as its shelf life and the amenability with the route of delivery.